Details
| Stereochemistry | ACHIRAL |
| Molecular Formula | C12H20N6O |
| Molecular Weight | 264.3268 |
| Optical Activity | NONE |
| Defined Stereocenters | 0 / 0 |
| E/Z Centers | 0 |
| Charge | 0 |
SHOW SMILES / InChI
SMILES
NC1=NC=NC2=C1N=CN2CCNCCCCCO
InChI
InChIKey=CVPTTZZCRDVGSU-UHFFFAOYSA-N
InChI=1S/C12H20N6O/c13-11-10-12(16-8-15-11)18(9-17-10)6-5-14-4-2-1-3-7-19/h8-9,14,19H,1-7H2,(H2,13,15,16)
| Molecular Formula | C12H20N6O |
| Molecular Weight | 264.3268 |
| Charge | 0 |
| Count |
|
| Stereochemistry | ACHIRAL |
| Additional Stereochemistry | No |
| Defined Stereocenters | 0 / 0 |
| E/Z Centers | 0 |
| Optical Activity | NONE |
DescriptionCurator's Comment: description was created based on several sources, including:
https://idsa.confex.com/idsa/2008/webprogram/Paper26299.html
Curator's Comment: description was created based on several sources, including:
https://idsa.confex.com/idsa/2008/webprogram/Paper26299.html
NB-001, an oil-in-water emulsion containing high energy nanometer-sized droplets stabilized by surfactants is designed for topical treatment of herpes labialis infections. NB-001 diffuses through the stratum corneum via the follicular route to accumulate in the epidermal and dermal tissues, without disrupting the normal epithelial matrix. The concentrations achieved in the epidermis and dermis are well above the concentrations required for antiviral activity.
Originator
Approval Year
Sample Use Guides
Subjects applied 200 µL of NB-001 (0.1%, 0.3%, 0.5%) 5 times daily for a maximum of 4 days.
Route of Administration:
Topical
Strains of HSV-1and HSV-2 (3 x 105 - 7.5 x 106 pfu/ml) were exposed to different concentrations of NB-001 for 15 minutes at room temperature and residual live virus was measured in a standard plaque-forming assay. The IC95 values of NB-001 against either HSV-1 or -2 virus ranged from 3 - 14 μg/ml.
| Substance Class |
Chemical
Created
by
admin
on
Edited
Mon Mar 31 21:59:15 GMT 2025
by
admin
on
Mon Mar 31 21:59:15 GMT 2025
|
| Record UNII |
J89QT81NBQ
|
| Record Status |
Validated (UNII)
|
| Record Version |
|
-
Download
| Name | Type | Language | ||
|---|---|---|---|---|
|
Preferred Name | English | ||
|
Official Name | English | ||
|
Common Name | English | ||
|
Code | English | ||
|
Common Name | English | ||
|
Systematic Name | English |
| Code System | Code | Type | Description | ||
|---|---|---|---|---|---|
|
DB12716
Created by
admin on Mon Mar 31 21:59:15 GMT 2025 , Edited by admin on Mon Mar 31 21:59:15 GMT 2025
|
PRIMARY | |||
|
J89QT81NBQ
Created by
admin on Mon Mar 31 21:59:15 GMT 2025 , Edited by admin on Mon Mar 31 21:59:15 GMT 2025
|
PRIMARY | |||
|
13341
Created by
admin on Mon Mar 31 21:59:15 GMT 2025 , Edited by admin on Mon Mar 31 21:59:15 GMT 2025
|
PRIMARY | |||
|
686301-48-4
Created by
admin on Mon Mar 31 21:59:15 GMT 2025 , Edited by admin on Mon Mar 31 21:59:15 GMT 2025
|
PRIMARY | |||
|
DTXSID30384648
Created by
admin on Mon Mar 31 21:59:15 GMT 2025 , Edited by admin on Mon Mar 31 21:59:15 GMT 2025
|
PRIMARY | |||
|
2815031
Created by
admin on Mon Mar 31 21:59:15 GMT 2025 , Edited by admin on Mon Mar 31 21:59:15 GMT 2025
|
PRIMARY |
| Related Record | Type | Details | ||
|---|---|---|---|---|
|
ACTIVE MOIETY |
central analgesic
|